Jeffrey Raser

Jeffrey Raser appears in our data through filings on Somaxon Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 25 September 2006 and 7 March 2011, the trades on record add up to 44 filings.

Both buying and selling appear: 1 purchase worth €8,850, against 30 sales worth €1.3M. On balance, insiders were net sellers of €1.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants and 6 option exercises. So far in 2011, the count stands at no purchases and 1 sale.

Most recently, on 9 March 2011, the filings show a share grant in Somaxon Pharmaceuticals, Inc. The last purchase on record was published on 26 May 2009, which is 6,376 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.